Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,262 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and Safety of Transarterial Chemoembolization for the Treatment of Unresectable Hepatocellular Carcinoma Associated with Bile Duct Tumor Thrombus: A Real-World Retrospective Cohort Study.
Feng JK, Sun JX, Liu ZH, Gu JW, Chen ZH, Liu C, Guo WX, Shi J, Cheng SQ. Feng JK, et al. Among authors: liu c, liu zh. Cancer Manag Res. 2021 Apr 28;13:3551-3560. doi: 10.2147/CMAR.S307065. eCollection 2021. Cancer Manag Res. 2021. PMID: 33953609 Free PMC article.
Prognostic Comparison Between Liver Resection and Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma Patients With Bile Duct Tumor Thrombus: A Propensity-Score Matching Analysis.
Liu ZH, Sun JX, Feng JK, Yang SY, Chen ZH, Liu C, Chai ZT, Mao FF, Guo WX, Shi J, Cheng SQ. Liu ZH, et al. Among authors: liu c. Front Oncol. 2022 Mar 15;12:835559. doi: 10.3389/fonc.2022.835559. eCollection 2022. Front Oncol. 2022. PMID: 35372001 Free PMC article.
Perioperative and long-term survival outcomes of laparoscopic versus laparotomic hepatectomy for BCLC stages 0-A hepatocellular carcinoma patients associated with or without microvascular invasion: a multicenter, propensity score matching analysis.
Yang SY, Yan ML, Duan YF, Feng JK, Ye JZ, Xiang YJ, Liu ZH, Guo L, Xue J, Cheng SQ, Guo WX. Yang SY, et al. Among authors: liu zh. Hepatol Int. 2022 Aug;16(4):892-905. doi: 10.1007/s12072-022-10353-4. Epub 2022 Jun 15. Hepatol Int. 2022. PMID: 35704267
Efficacy and safety of transarterial chemoembolization plus antiangiogenic- targeted therapy and immune checkpoint inhibitors for unresectable hepatocellular carcinoma with portal vein tumor thrombus in the real world.
Feng JK, Liu ZH, Fu ZG, Chai ZT, Sun JX, Wang K, Cheng YQ, Zhu HF, Xiang YJ, Zhou LP, Shi J, Guo WX, Zhai J, Cheng SQ. Feng JK, et al. Among authors: liu zh. Front Oncol. 2022 Nov 25;12:954203. doi: 10.3389/fonc.2022.954203. eCollection 2022. Front Oncol. 2022. PMID: 36505818 Free PMC article.
Intensity-modulated radiotherapy combined with systemic atezolizumab and bevacizumab in treatment of hepatocellular carcinoma with extrahepatic portal vein tumor thrombus: A preliminary multicenter single-arm prospective study.
Wang K, Xiang YJ, Yu HM, Cheng YQ, Liu ZH, Zhong JY, Feng S, Ni QZ, Zhu HF, Pan WW, Li JJ, Liang C, Zhou HK, Meng Y, Lau WY, Cheng SQ. Wang K, et al. Among authors: liu zh. Front Immunol. 2023 Feb 16;14:1107542. doi: 10.3389/fimmu.2023.1107542. eCollection 2023. Front Immunol. 2023. PMID: 36875125 Free PMC article.
2,262 results